Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis.

Published in: Rheumatology advances in practice (2019)

A significant proportion of patients continued TNFi despite demonstrated sub-optimal response. Further research needs to be undertaken in order to understand this group.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
rheumatoid arthritis